Company Overview

Assure Holdings Corp. is a healthcare services company focused on intraoperative neuonitoring (IONM), a clinical service used during surgeries to help reduce the risk of neurological injury. The company operates within the healthcare services and neurodiagnostic monitoring industries, providing real-time monitoring and interpretation of neural signals during surgical procedures. Assure’s services are commonly used in spine, neurosurgical, orthopedic, vascular, and other complex procedures where nerve integrity monitoring is clinically relevant. The company generates revenue primarily through professional neurodiagnostic services performed in coordination with surgeons, hospitals, and ambulatory surgery centers.

The company’s core business model combines remote neurologist oversight, technologist staffing, and proprietary workflow coordination to support surgical teams during operations. Assure Holdings has positioned itself as a specialized outsourced IONM provider with a focus on physician relationships, operational scale, and reimbursement management. The company was founded in 2010 and expanded through acquisitions and regional partnerships to build a national footprint in the United States. Public filings and investor disclosures indicate that the company has evolved from a regional provider into a broader platform focused on operational efficiency, payer contracting, and technology-enabled monitoring services.

Business Operations

Assure Holdings conducts its operations primarily through its IONM services business, which coordinates technologists, neurologists, and surgical providers to deliver intraoperative monitoring support. Revenue is principally derived from reimbursement for neurodiagnostic monitoring services billed to commercial insurers, government healthcare programs, hospitals, and other healthcare entities. The company’s operational model relies on certified technologists present during procedures and remote interpretation by supervising neurologists. Assure has historically emphasized scalable operational infrastructure, centralized scheduling, and billing capabilities as core business functions.

The company’s operations are concentrated in the United States, though it supports procedures across multiple states through regional clinical teams and physician networks. Assure Holdings has controlled or operated through subsidiaries associated with professional medical services and monitoring operations, including entities tied to physician practice management and neurodiagnostic support services. Public disclosures also reference relationships with surgeons, healthcare systems, ambulatory surgery centers, and contracted neurologists as central to service delivery. Data regarding certain operational partnerships and contract structures is limited in public disclosures, and some details remain inconclusive based on available public sources.

Strategic Position & Investments

Assure Holdings’ strategic direction has centered on expanding procedural volume, improving reimbursement collections, strengthening payer relationships, and increasing operational efficiency within the IONM market. Company filings and investor materials have highlighted efforts to optimize revenue cycle management, reduce administrative costs, and pursue selective expansion opportunities in high-volume surgical markets. The company has also focused on leveraging telemedicine-style remote monitoring capabilities to support broader geographic coverage and neurologist utilization efficiency.

Historically, Assure Holdings pursued acquisitions and practice affiliations to increase market density and physician access. The company has referenced investments in workflow technology, data systems, and centralized operating infrastructure intended to support scalable monitoring operations. Strategic priorities disclosed in public filings have also included maintaining compliance with evolving reimbursement frameworks and adapting to changing healthcare utilization trends. While the company has discussed technology-enabled healthcare delivery and monitoring efficiencies, publicly available information does not indicate material ownership of proprietary medical device manufacturing assets or major investments outside the neurodiagnostic services sector.

Geographic Footprint

Assure Holdings is headquartered in Denver, Colorado, and operates primarily within the United States healthcare market. The company has historically provided IONM services across multiple states through distributed clinical teams, contracted neurologists, and relationships with hospitals and ambulatory surgery centers. Its operational footprint has included surgical facilities in regions such as the Western United States, Midwestern United States, and Southern United States, depending on physician coverage and contractual arrangements.

The company’s market presence is domestic rather than multinational, with public filings primarily focused on U.S.-based healthcare operations and reimbursement systems. Assure’s business model depends on regional healthcare relationships and nationwide remote monitoring coordination rather than international expansion. Available public information does not indicate significant direct international operations or foreign subsidiaries. Data regarding any limited cross-border activities or international service arrangements is inconclusive based on available public sources.

Leadership & Governance

Assure Holdings is governed by a board of directors and executive leadership team with backgrounds in healthcare operations, finance, neurodiagnostics, and medical services administration. Corporate governance practices are disclosed through public company filings, including annual reports and securities filings. Leadership strategy has emphasized operational discipline, payer optimization, scalable healthcare delivery, and expansion of surgeon and facility relationships within the IONM sector.

Key executives and leadership figures disclosed in recent public filings have included:

• John A. Farlinger – Executive Chairman
• Daniel A. Rabinowitz – Chief Executive Officer
• Michael B. McConnell – Chief Financial Officer
• David Gruber, M.D. – Director and medical leadership contributor

Public disclosures indicate that leadership has focused on improving financial performance, increasing procedural utilization, and adapting to reimbursement and healthcare market dynamics. Executive composition and titles may change over time based on board appointments and corporate restructuring activities disclosed in subsequent filings.